ALGS — Aligos Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Aligos Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	191	126	136	56.9	77.8
Total Other Current Assets
Total Current Assets	204	134	141	62.1	82.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	15	12.5	9.82	7.33	4.96
Long Term Investments
Other Long Term Assets
Total Assets	235	147	152	70.1	88.5
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	39	33.1	23.9	21.7	21.2
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	50.6	42.8	59.4	99.1	35
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	185	104	92.1	-29	53.5
Total Liabilities & Shareholders' Equity	235	147	152	70.1	88.5
Total Common Shares Outstanding